Results for
"[search-keyword]"
Sponsor content
252 result(s) found, displaying 71 to 80
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Guselkumab
-
Prescription medicine decision summaryTGA decision: Spravato (esketamine hydrochloride) is approved for the treatment of treatment resistant depression.
-
Prescription medicine registrationActive ingredients: esketamine hydrochloride.
-
-
-
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
-
Prescription medicine registrationActive ingredients: apalutamide.